DXS INTERNATIONAL PLC
Notification of Significant Shareholding and
PDMR Dealing
The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems has been notified that a company owned and controlled by the Chief Executive’s wife, has acquired 1,000,000 Ordinary Shares in the Company at a price of 10p per share on 27 September 2019. The shares were purchased from Mr Ron Rhodes whose holding in the Company consequently falls to 2,000,000 Ordinary Shares constituting 5.62%.
Following the transaction specified above Mr Immelman interest, including those of persons closely associated with him, is 4,743,466 Ordinary Shares representing 13.33% of the issued share capital of the Company.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
| a) | Name | DL Services Limited, a company owned and controlled by Lorraine Immelman | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | Person closely associated with Chief Executive Officer David Immelman | |||
| b) | Initial notification /Amendment | Initial | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | DXS INTERNATIONAL PLC | |||
| b) | LEI | 2138001R1KEUWTXEVJ44 | |||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
| a) | Description of the financial instrument, type of instrument | Ordinary Shares of 0.33p each | |||
| Identification code | ISIN GB00B2Q6HZ92 | ||||
| b) | Nature of the transaction | Purchase | |||
| c) | Price(s) and volume(s) | ||||
| Price(s) | Volume(s) | ||||
| 10p | 1,000,000 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume | |||||
| - Price | |||||
| e) | Date of the transaction | 27 September 2019 | |||
| f) | Place of the transaction | Outside a trading venue | |||
The Directors of DXS International plc accept responsibility for this announcement
Enquiries:
| David Immelman (Chief Executive) DXS International plc | 01252 719800 david@dxs-systems.com |
| Wrecclesham House Wrecclesham Road Farnham Surrey GU10 4PS | |
| www.dxs-systems.co.uk |
| David Papworth City & Merchant | 0207 101 7676 info@cityandmerchant.com |
| Level 17, Dashwood House 69 Old Broad Street, London EC2M 1QS |
Note to Editors:
DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively which should significantly contribute towards the NHS achieving its projected efficiency savings.